Percutaneous closure of the patent foramen ovale (PFO) is generally regarded as a safe and effective procedure, indicated in patients with a prior PFO-associated stroke. While it is highly safe, rarely, it could be accompanied by a migration of the device, mainly caused by the interplay of a specific PFO morphology and inappropriate device sizing. Herein, we outline a seldom-observed complication of an unintentional detachment of the PFO closure device during implantation, leading to its migration into the abdominal aorta, and a unique management approach. Due to the inability to recapture the occluder with a snare, which is considered to be a mainstay of endovascular retrieval methods, two coronary guidewires were maneuvered through the mesh of the occluder and then captured with a snare proximally to the occluder. This innovative dual-wire–snare system was carefully pulled to the common femoral artery, a position deemed suitable for surgical extraction via arteriotomy, which was achieved successfully.
Artificial intelligence (AI) is being investigated across the acute coronary syndrome (ACS) care pathway, including early diagnosis, coronary lesion characterization, procedural guidance, and risk prediction. This comprehensive review examines the current evidence across the entire ACS trajectory, with particular emphasis on clinically actionable and interventional applications. AI-enabled electrocardiography (ECG) may improve detection of myocardial infarction, including occlusion myocardial infarction (OMI) that does not meet conventional STEMI criteria. Models combining clinical data and high-sensitivity troponin may improve early rule-out and rule-in. In coronary imaging, AI can quantify plaque characteristics and assist with the interpretation of OCT and IVUS, while image-derived physiology may help assess non-culprit lesions. However, better diagnostic accuracy does not necessarily translate into better revascularization decisions. AI-based models can also estimate post-ACS ischemic, bleeding, and mortality risk, although evidence that their use improves treatment or outcomes remains limited. The next priority is prospective evaluation of whether these tools improve decisions, workflow, and patient outcomes across diverse clinical settings.